These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24782260)

  • 21. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
    Price JC; Terrault NA
    Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.
    Meissner EG
    Curr Opin Gastroenterol; 2017 May; 33(3):120-127. PubMed ID: 28234770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
    Feeney ER; Chung RT; Yazdanpanah Y
    Curr Opin HIV AIDS; 2015 Sep; 10(5):323-9. PubMed ID: 26248119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
    Van den Eynde E; Crespo M; Esteban JI; Jardi R; Ribera E; Carbonell J; Rodríguez-Frias F; Falco V; Curran A; Imaz A; Villar del Saz S; Ocaña I; Esteban R; Pahissa A
    Clin Infect Dis; 2009 Apr; 48(8):1152-9. PubMed ID: 19275492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database.
    Puhr R; Wright ST; Hoy JF; Templeton DJ; Durier N; Matthews GV; Russell D; Law MG
    Sex Health; 2017 Aug; 14(4):345-354. PubMed ID: 28482168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin.
    Bhagani S
    Curr Opin HIV AIDS; 2011 Nov; 6(6):483-90. PubMed ID: 22001893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to the management of hepatitis C in haemophilia in 2012.
    Zoulim F; Bailly F
    Haemophilia; 2012 Jul; 18 Suppl 4():28-33. PubMed ID: 22726079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
    Macías J; López-Cortés LF; Téllez F; Recio E; Ojeda-Burgos G; Ríos MJ; Rivero-Juárez A; Delgado M; Rivas-Jeremías ; Pineda JA
    PLoS One; 2015; 10(12):e0143492. PubMed ID: 26640956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future perspectives: towards interferon-free regimens for HCV.
    Gane E
    Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
    Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
    Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplantation.
    Fredrick RT; Hassanein TI
    J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S14-22. PubMed ID: 15597023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.
    Del Bello D; Ita Nagy F; Hand J; Khedemi R; Lécluse-Barth J; Dieterich D; Piroth L
    Curr Opin HIV AIDS; 2015 Sep; 10(5):337-47. PubMed ID: 26248121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
    Rodríguez-Torres M; Rodríguez-Orengo JF; Ríos-Bedoya CF; Fernández-Carbia A; González-Lassalle E; Salgado-Mercado R; Marxuach-Cuétara AM
    J Clin Virol; 2007 Jan; 38(1):32-8. PubMed ID: 17064957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards hepatitis C eradication from the HIV-infected population.
    Barreiro P; Fernandez-Montero JV; de Mendoza C; Labarga P; Soriano V
    Antiviral Res; 2014 May; 105():1-7. PubMed ID: 24534673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.